Literature DB >> 17427356

Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology.

David Egilman1, Samantha Howe.   

Abstract

In response to several articles on corporate corruption of science that appeared earlier in this journal, a critic outlined an epistemological model based on an unsupported assertion that epidemiologic evidence is always required to support cause-effect relationships. This model, if adopted, would eliminate compensation to victims of toxic exposures and impede regulation of accepted hazards. Epidemiology is only one element in support of cause-effect determinations. The critic's proposal of an anti-health epidemiology was initially developed by corporations with the goal of providing defense in litigation, and is based not on science but on a corporate need to enhance profits at the expense of public health.

Mesh:

Substances:

Year:  2007        PMID: 17427356     DOI: 10.1179/107735207800244938

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  3 in total

1.  Cancer incidence and mortality among temporary maintenance workers in a refinery/petrochemical complex in Korea.

Authors:  Dong-Hee Koh; Eun-Kyo Chung; Jae-Kil Jang; Hye-Eun Lee; Hyang-Woo Ryu; Kye-Mook Yoo; Eun-A Kim; Kyoo-Sang Kim
Journal:  Int J Occup Environ Health       Date:  2014-03-20

2.  Dust diseases and the legacy of corporate manipulation of science and law.

Authors:  David Egilman; Tess Bird; Caroline Lee
Journal:  Int J Occup Environ Health       Date:  2014-03-04

3.  Ongoing downplaying of the carcinogenicity of chrysotile asbestos by vested interests.

Authors:  Xaver Baur; Arthur L Frank
Journal:  J Occup Med Toxicol       Date:  2021-02-23       Impact factor: 2.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.